Parthenon Looks to Keep KBRA With $1.7 Billion Continuation Fund

Parthenon Capital Partners is pitching investors on a secondary transaction that will allow it to hold on to credit grader ...
The Express Tribune

PM Sunak cancels meeting with Greek PM over Parthenon sculptures

Greek Prime Minister Kyriakos Mitsotakis accused his British counterpart Rishi Sunak of cancelling a scheduled meeting in London on Tuesday in a diplomatic row over the status of the Parthenon ...
China Daily Global Edition

Parthenon marbles deal close says Greece

According to official sources cited by The Guardian, discussions between Greece's Foreign Ministry and the chairman of the British Museum, George Osborne, are nearing a potential deal to return the ...
Artnet

The U.K. Has Held Onto the Parthenon Marbles for Centuries—But the Tide Is Turning. Here’s Why I Expect Them to Be Returned by 2030

Twenty-five years ago, in the preface to the 1997 edition of his book The Parthenon Marbles, Christopher Hitchens observed that “those who support the status quo at the British Museum have the great ...
Artnet

The Parthenon Marbles Dispute: From the Slopes of Mount Pentelikos

The following essay has been adapted from the new book The Parthenon Marbles Dispute: Heritage, Law, Politics (Hart / Bloomsbury, 2023) by Alexander Herman, director of the Institute of Art and Law. I ...
WKRN-TV

Nashville Parthenon: How Music City became home to the world’s only exact replica of a famous Greek temple

NASHVILLE, Tenn. (WKRN) — In downtown Nashville, you’ll find a structure built for a Titan—a whole team of them in fact—but a few miles away stands a replica of a structure once built for a god. Deep ...
WKRN-TV

Nashville has a Parthenon replica, here’s why

NASHVILLE, Tenn. (WKRN) — Nashville’s Parthenon was never meant to be a permanent structure. So, why is it here? The Tennessee State Library and Archives has several materials documenting the ...
Business Wire

Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announced a $65 million ...